What's Happening?
Primadulcine, a new active ingredient derived from primrose, has been introduced by Greenpharma. This COSMOS Approved ingredient is designed to combat the effects of chronic stress on the skin, such as loss of thickness and elasticity. Primadulcine targets
the enzyme responsible for cortisol synthesis, helping to limit stress-induced skin aging. Ex vivo studies show significant increases in hyaluronic acid, collagen III, and elastin synthesis. In vivo, it reduces wrinkle depth and improves skin appearance. Primadulcine is part of Sweetch's portfolio, emphasizing high-performance, bio-inspired actives for sensitive and stress-prone skin.
Why It's Important?
The introduction of Primadulcine addresses a growing demand for skincare solutions that mitigate the effects of stress on the skin. As stress is a common factor in skin aging, this ingredient offers a targeted approach to improving skin health and appearance. The development of such bio-inspired actives reflects a broader trend in the cosmetics industry towards natural and sustainable ingredients. Primadulcine's effectiveness in enhancing skin elasticity and reducing wrinkles could make it a valuable addition to skincare formulations, appealing to consumers seeking holistic beauty solutions.
What's Next?
Primadulcine will be showcased at in-cosmetics Global 2026, where industry professionals can learn more about its benefits and applications. Greenpharma's continued innovation in plant-based actives may lead to further advancements in skincare technology. As consumer interest in natural and effective skincare products grows, Primadulcine could see widespread adoption in cosmetic formulations. The success of this ingredient may encourage further research and development in bio-inspired skincare solutions, potentially setting new standards in the industry.
